These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34192638

  • 1. Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Golden AR, Fear T, Baxter M, Adam HJ, Martin I, Demczuk W, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115447. PubMed ID: 34192638
    [Abstract] [Full Text] [Related]

  • 2. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174
    [Abstract] [Full Text] [Related]

  • 3. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
    Golden AR, Adam HJ, Baxter M, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2021 Sep 15; 39(39):5474-5483. PubMed ID: 34454785
    [Abstract] [Full Text] [Related]

  • 4. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii20-vii31. PubMed ID: 29982573
    [Abstract] [Full Text] [Related]

  • 5. PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.
    Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, ElSherif M, McNeil SA, LeBlanc JJ.
    J Microbiol Methods; 2018 Jan 01; 144():99-106. PubMed ID: 29162393
    [Abstract] [Full Text] [Related]

  • 6. Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
    Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2015 Jul 01; 70(7):1960-4. PubMed ID: 25761605
    [Abstract] [Full Text] [Related]

  • 7. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z, Groves N, Sheppard CL, Litt D, Fry NK, Andrews N, Ladhani SN.
    Vaccine; 2021 Apr 01; 39(14):1997-2004. PubMed ID: 33715901
    [Abstract] [Full Text] [Related]

  • 8. Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    Adam HJ, Golden AR, Karlowsky JA, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii12-vii19. PubMed ID: 29982572
    [Abstract] [Full Text] [Related]

  • 9. Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada.
    Duvvuri VR, Deng X, Teatero S, Memari N, Athey T, Fittipaldi N, Gubbay JB.
    Infect Genet Evol; 2016 Aug 01; 42():1-8. PubMed ID: 27071529
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M, Urushibara N, Aung MS, Ito M, Takahashi A, Habadera S, Kobayashi N.
    J Infect Public Health; 2020 Aug 01; 13(8):1094-1100. PubMed ID: 32446777
    [Abstract] [Full Text] [Related]

  • 11. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A.
    Expert Rev Vaccines; 2021 Jan 01; 20(1):45-57. PubMed ID: 33507135
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V, Furberg AS, Slotved HC, Bazhukova T, Haldorsen B, Caugant DA, Sundsfjord A, Valentiner-Branth P, Simonsen GS.
    BMC Infect Dis; 2020 Apr 15; 20(1):279. PubMed ID: 32293324
    [Abstract] [Full Text] [Related]

  • 13. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J, Sundaresan S, Manoharan A, Shet A.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [Abstract] [Full Text] [Related]

  • 14. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
    Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG, Toronto Bacterial Diseases Network, Canadian Public Health Laboratory Network.
    Can J Microbiol; 2013 Dec 16; 59(12):778-88. PubMed ID: 24313450
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
    Khan MN, Pryharski K, Pichichero ME.
    Vaccine; 2018 Sep 11; 36(38):5701-5708. PubMed ID: 30107993
    [Abstract] [Full Text] [Related]

  • 16. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR, Good CE, Bajaksouzian S, Windau AR.
    Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493
    [Abstract] [Full Text] [Related]

  • 17. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, Hu B, Hu Z, Liao K, Sun H, Zhang R, Cao B, Zhuo C, Jia W, Mei Y, Chu Y, Xu X, Yang Q, Jin Y, Fu Q, Xu X, Li H, Wang L, Ni Y, Liang H, Wang H.
    BMC Infect Dis; 2017 Dec 29; 17(1):804. PubMed ID: 29284419
    [Abstract] [Full Text] [Related]

  • 18. Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine.
    Adam HJ, Karlowsky JA, Nichol KA, Gilmour MW, Hoban DJ, Embree J, Zhanel GG.
    Microb Drug Resist; 2012 Apr 29; 18(2):176-82. PubMed ID: 22204595
    [Abstract] [Full Text] [Related]

  • 19. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016.
    Furuya Y, Yamagishi Y, Okade H, Kadota T, Funatsu T, Eto M, Nomura N, Mitsuyama J, Mikamo H.
    J Infect Chemother; 2017 Jun 29; 23(6):394-399. PubMed ID: 28427991
    [Abstract] [Full Text] [Related]

  • 20. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.
    Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.